iomeprol has been researched along with Epilepsy in 1 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
Epilepsy: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Iomeprol was well tolerated in both rats and dogs following weekly intrathecal administrations for four weeks of doses up to three times higher than those foreseen for clinical use." | 1.29 | Preclinical safety assessment of iomeprol for injection as contrast medium for myelography. ( Bertani, F; de Haën, C; La Noce, A; Lorusso, V; Luzzani, F; Tirone, P, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| La Noce, A | 1 |
| Bertani, F | 1 |
| Lorusso, V | 1 |
| Luzzani, F | 1 |
| Tirone, P | 1 |
| de Haën, C | 1 |
1 other study available for iomeprol and Epilepsy
| Article | Year |
|---|---|
Preclinical safety assessment of iomeprol for injection as contrast medium for myelography.
Topics: Animals; Anticonvulsants; Blood; Contrast Media; Dogs; Drinking; Drug Interactions; Electroencephalo | 1994 |